An observational study in Irritable Bowel Syndrome, Fibromyalgia and Chronic Fatigue Syndrome, sponsored by University of Aarhus. Completed. Open to participants aged 18 Years to 84 Years. Per ClinicalTrials.gov, last updated 2022-12-05.
Sponsored by University of Aarhus · Observational
The objective of this study is to explore the role of neuroticism, perceived stress, and adverse life events, respectively, in the development and perpetuation of functional somatic disorders.
Functional somatic disorders (FSD) are common disorders with a multifactorial aetiology involving biological, social, and psychological factors. An often used explanation of the illness mechanisms behind FSD which is provided to the patients is, that FSD may be understood as a multi systemic physical response to stress. This relationship can be modelled as proposed in the Cognitive Behavioural Therapy (CBT) model of emotional distress where several cognitive, behavioural and psychological factors are thought to contribute to the onset and perpetuation of FSD. Personality traits e.g. neuroticism contribute to give rise to our cognitive, behavioural, and psychological reactions. Furthermore, neuroticism with its heightened reactivity to stressors, has shown to be an important predictor of a generic vulnerability to both physical and psychological conditions. Having been exposed to previous adverse life events/traumas and childhood adversities has also showed to impact the risk of having FSD. This relationship has been proposed to be induced by a heightened response to stimuli, i.e. sensitisation, caused by physical and emotional distress triggering a hormonal cascade in the hypothalamus pituitary adrenal (HPA) axis.
So far, most studies into these aspects have been carried out in selected patient samples, and general population-based studies including a large randomly obtained sample are sparse. In three recent population-based studies, strong associations between FSD and neuroticism, perceived stress, and the accumulated number of experienced adverse life events (ALE), respectively, have been established. However, these studies were cross-sectional, thereby not providing insight to whether these factors were risk factors of FSD. More studies are needed for further elucidation on these aspects.
Objective The objective of this study is to explore the role of neuroticism, perceived stress, and the accumulated number of ALE, respectively, in the development and perpetuation of FSD.
Hypotheses
Higher neuroticism, higher perceived stress, and higher number of ALE at baseline are individual risk factors of having developed FSD in the 5-year period from baseline to follow-up:
FSD non-case at baseline → FSD case at follow-up
FSD case at baseline → FSD case at follow-up
Analytical plan All analyses will be performed using STATA version 17.0. Descriptive statistics will be presented for all the three continuous explanatory variables across FSD diagnoses. Depending on data distribution, descriptive statistics will be presented as means and standard deviations or medians and interquartile ranges.
Depending on number of incident and perpetuating cases at follow-up, a range of analyses will be conducted with the purpose of investigating if higher neuroticism, higher perceived stress, and higher accumulated number of ALE at baseline
The first choice of analyses For hypothesis one, multiple logistic regression models will be performed with incident FSD cases at follow-up as primary outcome and baseline neuroticism, perceived stress, and accumulated number of ALE as explanatory primary variables. The effect of neuroticism, perceived stress, and the accumulated number of ALE will be reported from the same analysis as the effect when controlled for the effect from the other primary explanatory variables. Odds ratio (OR) with 95% confidence intervals (CI) will be used as measure of association; an OR > 1 supports the hypothesis. The reference group will constitute participants without FSD at both baseline and follow-up. Reference value of neuroticism, perceived stress, and the accumulated number of ALE will be set as the median value of the total sample. In each analysis there will be controlled for the confounding effect of sex (with male as reference) and age (the median value of the total sample).
For hypothesis two, multiple logistic regression models will be performed with FSD cases perpetuating from baseline to follow-up as primary outcome and baseline neuroticism, self-perceived stress, and accumulated number of ALE as primary explanatory variable. The effect of neuroticism, perceived stress, and the accumulated number of ALE will be reported from the same analysis as the effect when controlled for the effect from the other primary explanatory variables. Odds ratio (OR) with 95% confidence intervals (CI) will be used as measure of association; an OR > 1 supports the hypothesis. The reference group will constitute participants with FSD at baseline but without FSD at follow-up. Reference value of neuroticism, perceived stress, and the accumulated number of ALE will be set as the median value of the total sample. In each analysis there will be controlled for the confounding effect of sex (with male as reference) and (the median value of the total sample).
The second choice of analyses
If number of incident and perpetuated cases at follow-up are too low to perform the above multiple logistic regression models with incorporation of the three primary explanatory variables in one analyses per FSD definition, it will be investigated if the confounding primary explanatory variables can be reduced into one variable and incorporated in separate analyses instead. Hence, instead of performing one analysis per FSD definition, three logistic regression analyses will be performed for each FSD definition:
To find out if the confounding primary explanatory variables can be reduced into one variable, principal component analyses will be performed.
The third choice of analyses If the second set of analyses cannot provide us with meaningful variables describing the primary explanatory variables, separate logistic regression analyses investigating the effect of neuroticism, perceived stress, and the accumulated number of ALE, respectively, will be performed with pre-defined prioritisation of confounders. The prioritisation will be as follows (depending on the primary explanatory variable): 1) neuroticism, 2) perceived stress, 3) accumulated number of ALE, 4) sex, and 5) age.
1,116 studies on the registry are indexed under Irritable Bowel Syndrome; 208 are open to participants now.
This study's enrollment of 7,493 is above the median of 160 across 191 observational studies indexed under Irritable Bowel Syndrome.
Browse Irritable Bowel Syndrome studies →University of Aarhus is the lead sponsor of 1,300 studies on the registry; 189 are open to participants now.
Counted across the registry records on this site, refreshed daily.
A total of 28773 participants were randomly drawn from the adult general Danish population by means of the the Danish Civil Registration system.
The DanFunD baseline cohort comprises a total of 9,656 (33.7% of invited participants) men and women aged 18-76 years, born in Denmark, and living in the Western part of greater Copenhagen.
The follow-up cohort (gathered in the years 2018-2020) consists of participants all born in Denmark, between 24 and 84 years of age. The follow-up cohort constitutes data from self-reported questionnaires (n=4,288) and diagnostic interviews data (n=1,094).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The baseline cohort (gathered in the years 2012-2015) is a random sample selected through the National Civil Registration system among people living in 10 municipalities in the western part of greater Copenhagen, Denmark, ages 18 to 76 years. The baseline cohort constitutes data from self-reported questionnaires (n=7,493) and diagnostic interviews data (n=1,590).
The follow-up cohort (gathered in the years 2018-2020) consists of participants all born in Denmark, between 24 and 84 years of age. The follow-up cohort constitutes data from self-reported questionnaires (n=4,288) and diagnostic interviews data (n=1,094).
Questionnaire-defined Functional somatic disorder at baseline
Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with self-reported questionnaires.
Time frame: At the DanFunD baseline investigation
Interview-based Functional somatic disorder at baseline
Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with diagnostic interviews.
Time frame: At the DanFunD baseline investigation
Questionnaire-defined Functional somatic disorder at 5-year follow-up
Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with self-reported questionnaires.
Time frame: At the DanFunD 5-year follow-up investigation
Interview-based Functional somatic disorder at 5-year follow-up
Participants fulfilling the diagnostic criteria of the unifying diagnostic concept Bodily Distress Syndrome single- and multi-organ type will be defined with diagnostic interviews.
Time frame: At the DanFunD 5-year follow-up investigation
Irritable bowel at baseline
Participants fulfilling the diagnostic criteria for irritable bowel will be identified with self-reported questionnaires
Time frame: At the DanFunD baseline investigation
Irritable bowel at 5-year follow-up
Participants fulfilling the diagnostic criteria for irritable bowel will be identified with self-reported questionnaires
Time frame: At the DanFunD 5-year follow-up investigation
Chronic widespread pain at baseline
Participants fulfilling the diagnostic criteria for chronic widespread pain will be identified with self-reported questionnaires
Time frame: At the DanFunD baseline investigation
Chronic widespread pain at 5-year follow-up
Participants fulfilling the diagnostic criteria for chronic widespread pain will be identified with self-reported questionnaires.
Time frame: At the DanFunD 5-year follow-up investigation
Chronic fatigue at baseline
Participants fulfilling the diagnostic criteria for chronic fatigue will be identified with self-reported questionnaires.
Time frame: At the DanFunD baseline investigation
Chronic fatigue at 5-year follow-up
Participants fulfilling the diagnostic criteria for chronic fatigue will be identified with self-reported questionnaires.
Time frame: At the DanFunD 5-year follow-up investigation
Neuroticism score at baseline
Measured with the Danish version of the short-form NEO Personality Inventory (NEO-PI-Rsf). It includes 60 self-descriptive statements each rated with a five-point rating scale from "strongly disagree" to "strongly agree". For the domain neuroticism, a sum score of 12 items, each ranging from 12 to 60, is calculated and higher score indicates higher neuroticism.
Time frame: Measured at baseline
Perceived Stress score at baseline
Measured with the Cohen's Perceived Stress Scale. It consists of 10 items each rated on a five-point rating scale from "never" to "very often". The sum score ranges from 0 to 40 and higher score indicates higher level of perceived stress.
Time frame: Measured at baseline
The accumulated number of adverse life events score at baseline
Measured with the Danish version of the Cumulative Lifetime Adversity Measure (CLAM). CLAM obtains exposure to lifetime adversity by asking the respondents whether they have experienced 37 different adverse life events plus a possibility to add one other unnamed life event. For a positive answer to an event, a number of event score is calculated by adding age time-points and age ranges by simply counting age time-points and age ranges, i.e. an age range counted for one event and an age time-point counted for one event. The sum score ranging from 0 to 130 with higher score indicating higher number of adversities.
Time frame: Measured at baseline
No study locations are listed for this record.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Restrictions apply to the availability of data according to Danish law, which means that data cannot be made publicly available. A request for collaboration or access to data can be sent to ckff@regionh.dk. An application for data should consist of a short synopsis of the study planned. Please see our website (www. danfund.org) for more information.
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.